Shockwave Medical, Inc. (NASDAQ:SWAV) Shares Sold by Baillie Gifford & Co.

Baillie Gifford & Co. decreased its holdings in Shockwave Medical, Inc. (NASDAQ:SWAV - Free Report) by 10.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 244,061 shares of the company's stock after selling 28,902 shares during the period. Baillie Gifford & Co. owned about 0.66% of Shockwave Medical worth $46,508,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Lindbrook Capital LLC increased its stake in shares of Shockwave Medical by 64.8% during the third quarter. Lindbrook Capital LLC now owns 150 shares of the company's stock valued at $30,000 after buying an additional 59 shares during the period. EverSource Wealth Advisors LLC boosted its position in Shockwave Medical by 297.4% during the third quarter. EverSource Wealth Advisors LLC now owns 155 shares of the company's stock valued at $31,000 after purchasing an additional 116 shares in the last quarter. PenderFund Capital Management Ltd. bought a new stake in Shockwave Medical during the first quarter valued at about $41,000. Asset Management One Co. Ltd. bought a new stake in Shockwave Medical during the fourth quarter valued at about $34,000. Finally, Operose Advisors LLC bought a new stake in Shockwave Medical during the third quarter valued at about $49,000. Hedge funds and other institutional investors own 95.35% of the company's stock.

Analyst Ratings Changes

SWAV has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and set a $335.00 price objective (up previously from $270.00) on shares of Shockwave Medical in a research report on Monday. SVB Leerink reaffirmed a "market perform" rating and set a $335.00 target price (down previously from $361.00) on shares of Shockwave Medical in a report on Monday. Leerink Partnrs cut Shockwave Medical from an "outperform" rating to a "market perform" rating in a research report on Friday, April 5th. Morgan Stanley restated an "equal weight" rating and issued a $335.00 price objective (up from $285.00) on shares of Shockwave Medical in a research report on Monday. Finally, CL King restated a "neutral" rating on shares of Shockwave Medical in a research report on Monday. Ten analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Hold" and an average target price of $305.70.

Shockwave Medical Price Performance

Shares of NASDAQ:SWAV traded up $2.29 during trading on Wednesday, reaching $329.64. The stock had a trading volume of 2,118,522 shares, compared to its average volume of 913,731. The company has a debt-to-equity ratio of 1.09, a quick ratio of 10.73 and a current ratio of 11.76. The business has a fifty day moving average price of $272.84 and a 200-day moving average price of $222.58. The stock has a market cap of $12.33 billion, a PE ratio of 85.18, a PEG ratio of 2.75 and a beta of 0.92. Shockwave Medical, Inc. has a 1-year low of $157.00 and a 1-year high of $331.58.

Shockwave Medical (NASDAQ:SWAV - Get Free Report) last issued its quarterly earnings results on Thursday, February 15th. The company reported $1.16 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.92 by $0.24. The firm had revenue of $202.98 million for the quarter, compared to analyst estimates of $199.43 million. Shockwave Medical had a return on equity of 23.97% and a net margin of 20.17%. The business's revenue was up 41.0% on a year-over-year basis. During the same period in the previous year, the company posted $3.71 earnings per share. On average, equities analysts forecast that Shockwave Medical, Inc. will post 4.89 earnings per share for the current fiscal year.

Insider Transactions at Shockwave Medical

In other Shockwave Medical news, CFO Dan Puckett sold 3,406 shares of the business's stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $229.76, for a total transaction of $782,562.56. Following the transaction, the chief financial officer now owns 27,732 shares of the company's stock, valued at $6,371,704.32. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other Shockwave Medical news, VP Trinh Phung sold 1,287 shares of the business's stock in a transaction on Tuesday, February 6th. The stock was sold at an average price of $232.18, for a total transaction of $298,815.66. Following the transaction, the vice president now owns 32,933 shares of the company's stock, valued at $7,646,383.94. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Dan Puckett sold 3,406 shares of the business's stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $229.76, for a total value of $782,562.56. Following the transaction, the chief financial officer now directly owns 27,732 shares in the company, valued at approximately $6,371,704.32. The disclosure for this sale can be found here. Insiders have sold 103,813 shares of company stock valued at $25,938,579 over the last ninety days. Insiders own 3.40% of the company's stock.

Shockwave Medical Profile

Shockwave Medical, Inc, a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels.